• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Eugia Steriles` New Injectables Facility Gets First FDA Product Approval

    ECONOMICTIMES

    Enforcement Report - Week of March 6, 2024

    FDA

    Pai`s Generic Lidocaine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of December 13, 2023

    FDA

    Enforcement Report - Week of November 15, 2023

    FDA

    Mankind`s Generic Lidocaine Hydrochloride Receives Approval in the U.S.

    FDA

    Mankind`s Generic Lidocaine Hydrochloride Receives Approval in the U.S.

    FDA

    Thea Pharma Statement Related to Akorn`s Recall of Various Human & Animal Drug

    PR NEWSWIRE

    Sintetica US launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%

    PR NEWSWIRE

    Enforcement Report - Week of February 8, 2023

    FDA

    Enforcement Report - Week of January 11, 2023

    FDA

    Enforcement Report - Week of September 14, 2022

    FDA

    Anesthesia drug Lignocaine reduces risk of metastasis breast cancer surgery

    ECONOMICTIMES

    Afaxys`s Generic Lidocaine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of May 11, 2022

    PRESS RELEASE

    Enforcement Report - Week of January 5, 2022

    FDA

    Health Biotech`s Lignocaine and Adrenaline Injection IP (ACAINE ADR INJ)

    MEDICALDIALOGUES

    Enforcement Report - Week of December 22, 2021

    FDA

    Teligent Pharma Recalls Lidocaine HCl Topical Solution USP 4%

    NASDAQ

    Teligent Pharma Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution USP 4%

    FDA

    Aspiro Pharma`s Generic Lidocaine Hydrochloride Receives Approval In US

    FDA

    Aspiro Pharma’s Generics Lidocaine Hydrochloride Receives Approvals In US

    FDA

    Teligent Pharma Issues Voluntary Recall of Lidocaine HCl Topical Solution 4%

    FDA

    Enforcement Report - Week of September 22, 2021

    FDA

    B Braun`s Generic Lidocaine HCl and Epinephrine Receives Approval in the US

    FDA

    Teligent Pharma, Inc.’s Issues Voluntary Recall of Lidocaine HCl Topical Solution 4%

    FDA

    Enforcement Report - Week of July 14, 2021

    FDA

    Enforcement Report- Week of June 9, 2021

    FDA

    Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection

    FDA

    Enforcement Report - Week of March 24, 2021

    FDA

    Enforcement Report - Week of December 9, 2020

    FDA

    Enforcement Report - Week of August 19, 2020

    FDA

    Enforcement Report - Week of June 3, 2020

    FDA

    Huons`s Generic Lidocaine Hydrochloride Receives Approval in US

    FDA

    Sandoz completes acquisition of Aspen’s Japanese operations, strengthening

    PRESS RELEASE

    Enforcement Report - Week of December 4, 2019

    FDA

    FDA Seeks to Pull 4 NDAs After Companies Failed to Submit Annual Reports

    RAPS

    Enforcement Report - Week of October 2, 2019

    FDA

    Akorn Inc. Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of April 17, 2019

    FDA

    Enforcement Report - Week of August 15, 2018

    FDA

    B Braun Medical`s Generic Lidocaine Hydrochloride Receives Approval in US

    FDA

    Viagra, anaesthetic found in ayurvedic potency pills

    TIMES OF INDIA

    Spectrum MDCL Devices Generic Lidocaine Hydrochloride Receives Approval In US

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Enforcement Report - Week of November 29, 2017

    FDA

    Zydus Pharm’s Generic Doxycycline Hyclate Receives Approval In US

    FDA

    Vitruvias Therap`s Generic Lidocaine Receives Approval In US

    FDA

    Pfizer Recalls Heparin and Lignocaine ampoules Due to Potential for Incorrect Products in Packages

    TGA

    Recall of blood thinner, dialysis drugs

    9NEWS

    Enforcement Report - Week of May 3, 2017

    FDA

    Enforcement Report - Week of March 1, 2017

    FDA

    Health Canada Approves First Teligent Topical Product

    PRNEWSWIRE

    After analysis, lots of product Lidostesim 3% are suspended

    ANVISA

    After deviation, Anvisa suspends batch of drug company Hypofarma

    ANVISA

    Anvisa suspends lot of Etna injectable drug

    ANVISA

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    FDA Drug Shortages: Lidocaine Hydrochloride (Xylocaine) Injection

    FDA

    Hospira Inc., Ongoing Class I recall of 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045 because of Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

    FDA

    Hospira Inc., Ongoing Class I recall of 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials, packaged in 25-count cartons, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4279-02. because of Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.